Imperial College London
Alternate

ProfessorUtaGriesenbach

Faculty of Medicine, National Heart & Lung Institute

Professor of Molecular Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7927u.griesenbach

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Griesenbach:2015:10.12703/P7-64,
author = {Griesenbach, U and Alton, EWFW},
doi = {10.12703/P7-64},
journal = {F1000Prime Rep},
title = {Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.},
url = {http://dx.doi.org/10.12703/P7-64},
volume = {7},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians and has been extensively studied for many decades. The cystic fibrosis transmembrane conductance regulator gene was identified in 1989. It encodes a complex protein which has numerous cellular functions. Our understanding of cystic fibrosis pathophysiology and genetics is constantly expanding and being refined, leading to improved management of the disease and increased life expectancy in affected individuals.
AU  - Griesenbach,U
AU  - Alton,EWFW
DO  - 10.12703/P7-64
PY  - 2015///
SN  - 2051-7599
TI  - Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.
T2  - F1000Prime Rep
UR  - http://dx.doi.org/10.12703/P7-64
UR  - https://www.ncbi.nlm.nih.gov/pubmed/26097737
VL  - 7
ER  -
Download